论文部分内容阅读
目的:构建肺癌数字化临床路径并研究其在临床中应用优势。方法:收集2013年8月-2016月3月于哈医大四院胸外二科入院的肺癌手术患者,150名患者通过肺癌数字化临床路径管理系诊治(临床路径组),150人通过常规方式诊疗(对照组),比较两组最终的住院天数和住院总费用。结果:临床路径组的住院总天数、住院总费用均小于对照组(P<0.05或0.01)。结论:数字化肺癌路径管理平台在临床病人管理中具有一定的优势。
Objective: To establish a digital clinical path of lung cancer and study its clinical advantages. Methods: Lung cancer patients undergoing chest surgery in the Second Affiliated Hospital of Harbin Medical University from August 2013 to March 2016 were collected. 150 patients were diagnosed and treated by digital clinical pathway management of lung cancer (clinical pathway group) and 150 were treated by conventional methods (Control group), the final length of hospital stay and total cost of hospitalization were compared between the two groups. Results: The total number of hospital stay and total cost of hospitalization in the clinical pathway group was less than that in the control group (P <0.05 or 0.01). Conclusion: The digital lung cancer path management platform has certain advantages in clinical patient management.